APOGEE THERAPEUTICS, INC. (APGE)
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
ELEDON PHARMACEUTICALS, INC. (ELDN)
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus
TRAWS PHARMA, INC. (TRAW)
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
NRX PHARMACEUTICALS, INC. (NRXP)
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression
DMC GLOBAL INC. (BOOM)
NobelClad Expands Capabilities in the Americas with Weld Overlay Services
GXO LOGISTICS, INC. (GXO)
GXO to Support Action’s Expansion Across Central and Southern Italy with New Distribution Center in Ferentino
LITHIUM ARGENTINA AG (LAR)
Lithium Argentina Reports 2026 Annual General Meeting Results
UMB FINANCIAL CORP (UMBF)
iCapital® and UMB Expand Blockchain-Enabled Network for Alternative Investments Through Distributed Ledger Technology Integration
DEFINIUM THERAPEUTICS, INC. (DFTX)
Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder
GENEDX HOLDINGS CORP. (WGS)
WGS INVESTOR NOTICE: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit